Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Context Therapeutics Inc

CNTX
Current price
1.9 USD -0.07 USD (-3.55%)
Last closed 2.05 USD
ISIN US21077P1084
Sector Healthcare
Industry Biotechnology
Exchange NASDAQ
Capitalization 146 246 704 USD
Yield for 12 month +87.19 %
1Y
3Y
5Y
10Y
15Y
CNTX
21.11.2021 - 28.11.2021

Context Therapeutics Inc., a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. The company has a collaboration and licensing agreement with Integral Molecular, Inc. for the development of a CLDN6 bispecific monoclonal antibody for cancer therapy. Context Therapeutics Inc. was incorporated in 2015 and is headquartered in Philadelphia, Pennsylvania. Address: 2001 Market Street, Philadelphia, PA, United States, 19103

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

7.38 USD

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-12 044 USD

Last Year

-9 268 USD

Current Quarter

Last Quarter

-2 568 USD

Key Figures CNTX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -20 014 956 USD
Operating Margin TTM
PE Ratio
Return On Assets TTM -19.19 %
PEG Ratio
Return On Equity TTM -29.68 %
Wall Street Target Price 7.38 USD
Revenue TTM
Book Value 0.74 USD
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -0.96 USD
Diluted Eps TTM -0.96 USD
Most Recent Quarter III 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics CNTX

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History CNTX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation CNTX

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA 1.5966
Price Book MRQ 1.4465

Financials CNTX

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators CNTX

For 52 weeks

0.77 USD 2.75 USD
50 Day MA 2.09 USD
Shares Short Prior Month 1 088 929
200 Day MA 1.8 USD
Short Ratio 2.79
Shares Short 1 025 078
Short Percent 1.54 %